The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model
Abstract
OBJECTIVE: The pleiotropic cytokine interleukin (IL)-6 seems to play a pivotal role in sepsis, but contradictory findings in animal models impede a rationale for therapies directed against IL-6. IL-6 signals by two mechanisms via the ubiquitous transmembrane glycoprotein 130 (gp130): "classic" signaling using membrane-bound IL-6 receptor (IL-6R) and trans-signaling using soluble IL-6R (sIL-6R). Trans-signaling is selectively inhibited by soluble gp130 (sgp130). The aim of this study was to systematically compare complete blockade of IL-6 signaling (using a neutralizing anti-IL-6 antibody) and selective blockade of IL-6 trans-signaling (using a fusion protein of sgp130 and the crystallizable fragment of immunoglobulin G1, sgp130Fc) in a standardized cecal ligation and puncture (CLP) sepsis model. DESIGN: Animal study. SETTING: Animal laboratory. SUBJECTS: C57BL/6J mice. INTERVENTIONS: We performed a 96-hr dose-response study and a 24-hr study to investigate short-term mechanisms. In the 96-hr study, CLP was performed in 120 randomized mice (20 mice received vehicle, 10 mice per dose group). Mice were treated with equimolar doses of sgp130Fc (0.01/0.1/1/10 mg/kg) or anti-IL-6 (0.008/0.08/0.8/8 mg/kg) 24 hrs before CLP. Two additional groups received 0.5 mg/kg sgp130Fc 24 hrs before or 1 mg/kg sgp130Fc 24 hrs after CLP. Survival and activity scores were obtained daily until 96 hrs after CLP. In the 24-hr study, mice were randomized into four groups with 10 animals each (sham/vehicle, CLP/vehicle, CLP/anti-IL-6 [0.8 mg/kg], and CLP/sgp130Fc [1 mg/kg]) and killed after 24 hrs. MEASUREMENTS AND MAIN RESULTS: In contrast to anti-IL-6, pretreatment with sgp130Fc significantly and dose-dependently increased survival from 45% to 100%. In addition, 1 mg/kg sgp130Fc administered 24 hrs after CLP increased survival from 45% to 80%. Mechanistically, sgp130Fc efficacy was reflected by complete prevention of epithelial cell apoptosis in the jejunum after CLP, which was not achieved with anti-IL-6. CONCLUSION: Selective inhibition of IL-6 trans-signaling by sgp130Fc has considerable potential for the treatment of sepsis and related disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inhibition of trans signaling via gp130 blockade in murine sepsis models rescues mice from widespread inflammation and death (41).”
From Macrophage Cytokines: Involvement in Immunity and Infectious Diseases (2014) · cites this paper as [41]
Citations
Cites
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Self-citationApoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction
Hotchkiss, R. S., Swanson, P. E., Freeman, B. D., Tinsley, K. W., Cobb, J. P., Matuschak, G. M., Buchman, T. G., & Karl, I. E. (1999) · Critical Care Medicine · doi:10.1097/00003246-199907000-00002 · Cited by 1,341
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V. W. M., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,124
Multiple-Organ-Failure Syndrome
Carrico, C. J. (1986) · Archives of Surgery · doi:10.1001/archsurg.1986.01400020082010 · Cited by 819
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811
Self-citationHubbard, W. J., Choudhry, M. A., Schwacha, M. G., Kerby, J. D., Rue, L. W., Bland, K. I., & Chaudry, I. H. (2005) · Shock · doi:10.1097/01.shk.0000191414.94461.7e · Cited by 801
[Multiple organ failure syndrome].
Simbirtsev, S. A., Beliakov, N. A., & Konychev, A. V. (1988) · PubMed · Cited by 796
Soluble receptors for cytokines and growth factors: generation and biological function
Rose‐John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 777
Self-citationBone, R. C. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-8-199610150-00009 · Cited by 718 · cited 1×
“T he cytokine interleukin-6 (IL-6) appears to be an important player in sepsis (1, 2), and a correlation between high IL-6 plasma levels and mortality in septic patients has been observed (3, 4).”
BackgroundSoluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M., & Rose-John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 665
Self-citation
Flagged first, then by citations
Research works printed but not linked: 5
- Peters, 1998, Blood, 92, 3495, 10.1182/blood.V92.10.3495 · DOI
- Narazaki, 1993, Blood, 82, 1120, 10.1182/blood.V82.4.1120.1120 · DOI · Paper page
- Chaudry, 1979, Surgery, 85, 205
- Nieuwenhuijzen, 1996, Eur J Surg, 162, 259
- Pastores, 1996, Am J Gastroenterol, 91, 1697
Cited by
Sorted by citations
Items 101–170 of 170
An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma
Elhusseini, Z. W., Khalenkow, D., Lan, A., van der Molen, T., Brightling, C. E., Papi, A. A., Rabe, K. F., Siddiqui, S., Singh, D., Kraft, M., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02617-w · Cited by 17
Self-citationSharma, D., Malik, A., Lee, E. H., Britton, R. A., & Parameswaran, N. (2013) · Infection and Immunity · doi:10.1128/iai.00653-13 · Cited by 16
Making anti-cytokine therapy more selective: Studies in mice
Drutskaya, M. S., Efimov, G. A., Astrakhantseva, I. V., Kruglov, A., & Nedospasov, S. A. (2016) · Cytokine · doi:10.1016/j.cyto.2016.08.022 · Cited by 17
Zenker, S., Panteleev-Ivlev, J., Wirtz, S. J., Kishimoto, T., Waldner, M. J., Ksionda, O., Tybulewicz, V. L. J., Neurath, M. F., & Atreya, I. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300157 · Cited by 16
Yadav, M. K., Singh, S. P., & Egwuagu, C. E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1514080 · Cited by 15
Schumacher, N., Thomsen, I., Brundert, F., Hejret, V., Düsterhöft, S., Tichý, B., Schmidt‐Arras, D., Voß, M., & Rose‐John, S. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119489 · Cited by 14
Self-citationAbdulaal, W. H., Helmi, N. M., Hamza, A. H., & Salem, N. A. (2024) · Cellular and Molecular Biology · doi:10.14715/cmb/2024.70.1.3 · Cited by 13
Wei, Y., Meng, M., Tian, Z., Xie, F., Yin, Q., Dai, C., Wang, J., Zhang, Q., Liu, Y., Liu, C., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.017 · Cited by 13
Bahari, Z., Jangravi, Z., Ghoshooni, H., Afarinesh, M. R., & Meftahi, G. H. (2021) · Inflammation Research · doi:10.1007/s00011-021-01445-2 · Cited by 13
IL-6 family cytokines as potential therapeutic strategies to treat metabolic diseases
Zhao, J., Turpin-Nolan, S. M., & Febbraio, M. A. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155549 · Cited by 12
Ettich, J., Werner, J., Weitz, H. T., Mueller, E., Schwarzer, R., Lang, P. A., Scheller, J., & Moll, J. M. (2021) · Journal of Virology · doi:10.1128/jvi.01622-21 · Cited by 12
Self-citationChen, Q., Shi, P., Wang, D., Liu, Q., Xu, L., Wang, Y., Zou, D., Huang, Z., Gao, X., & Lin, Z. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.01.012 · Cited by 11
Cell-Derived Nanoparticles are Endogenous Modulators of Sepsis With Therapeutic Potential
Kunz, N., Xia, B. T., Kalies, K., Klinger, M. H. F., Gemoll, T., Habermann, J. K., Whitacre, B. E., Seitz, A. P., Kalies, K., & Caldwell, C. C. (2017) · Shock · doi:10.1097/shk.0000000000000855 · Cited by 12
Nonspecific Inhibition of IL6 Family Cytokine Signalling by Soluble gp130
Widjaja, A. A., & Cook, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031363 · Cited by 10
Weitz, H. T., Ettich, J., Rafii, P., Wittich, C., Schultz, L., Frank, N. C., Heise, D., Krusche, M., Lokau, J., Garbers, C., et al. (2024) · FEBS Journal · doi:10.1111/febs.17309 · Cited by 11
Self-citationInterleukin-6 in non-infectious uveitis: Biology, experimentalevidence and treatment strategies.
Yu, X., Duan, R.-P., Jiang, L., Wang, T., Li, Z.-H., Zhang, B., Su, W.-R., & Lin, Y. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116605 · Cited by 12
Mahmud-Al-Rafat, A., Asim, M. M. H., Taylor-Robinson, A. W., Majumder, A., Muktadir, A., Muktadir, H., Karim, M., Khan, I., Ahasan, M. M., & Billah, M. M. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155228 · Cited by 10
Reyes-Ramos, C. A., Ramírez-Jirano, L. J., Bitzer-Quintero, O. K., Vázquez‐Medina, J. P., Gaxiola‐Robles, R., & Zenteno‐Savín, T. (2023) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2023.111438 · Cited by 9
PHYSIOLOGICAL FRACTURE HEALING IS UNAFFECTED BY NEUTROPHIL-DERIVED IL-6 OR IL-6R SIGNALING IN MICE
Fischer, V., Küppers, O., Steppe, L., Krüger, B. T., Hidalgo, J., Haffner‐Luntzer, M., & Ignatius, A. A. (2025) · Shock · doi:10.1097/shk.0000000000002615 · Cited by 8
Targeting the double-edged sword: cytokines in the pathogenesis and treatment of autoimmune diseases
Dandash, F., Salhab, Z., Issa, R., Dirani, Z. A., Hamze, M., Fares, G. H., Berro, F. J., Shaalan, F., Hamade, A., Merimi, M., et al. (2025) · InflammoPharmacology · doi:10.1007/s10787-025-01817-8 · Cited by 8
Xu, Y., Xu, C.-Z., Liang, Y., Jin, D., Ding, J., Sheng, Y., Zhang, L., & Deng, F. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2082978 · Cited by 7
Clavier, T., Besnier, E., Maucotel, J., Arabo, A., Desrues, L., Amki, M. E., Perzo, N., Richard, V. J., Tamion, F., Gandolfo, P., et al. (2019) · Shock · doi:10.1097/shk.0000000000001448 · Cited by 7
Dissecting Interleukin-6 Classic and Trans-signaling in Inflammation and Cancer
Garbers, C., & Rose‐John, S. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3331-1_16 · Cited by 7
Self-citationBorsum, N., Verboom, M., Ahlenstiel-Grunow, T., & Pape, L. (2019) · Transplantation Direct · doi:10.1097/txd.0000000000000943 · Cited by 7
Homeier, J.-M., Bundkirchen, K., Winkelmann, M., Graulich, T., Relja, B., Neunaber, C., & Macke, C. (2021) · Life · doi:10.3390/life11111252 · Cited by 6
Efficacy and prognostic analysis of the oXiris® filter in sepsis-associated acute kidney injury
He, S., Lou, J., Li, Y., Dou, Y.-N., & Yang, L. (2025) · International Urology and Nephrology · doi:10.1007/s11255-025-04533-y · Cited by 5
FGF15 Protects Septic Mice by Inhibiting Inflammation and Modulating Treg Responses
Li, X., Zhu, Z., Xia, Z., & Xu, B. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s387613 · Cited by 5
In vivo immunomodulation of IL6 signaling in a murine multiple trauma model
Malysch, T., Reinhold, J. M., Becker, C. A., Schmidt‐Bleek, K., & Kleber, C. (2022) · Immunologic Research · doi:10.1007/s12026-022-09319-3 · Cited by 4
Mukherjee, S., Ghosh, S., Bawali, S., Chatterjee, R., Saha, A., Sengupta, A., Keswani, T., Sarkar, S., Ghosh, P., Chakraborty, S., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110671 · Cited by 4
Time course of signaling profiles of blood leukocytes in acute pancreatitis and sepsis
Turunen, A., Kuuliala, A., Penttilä, A. K., Kaukonen, K., Mustonen, H. K., Pettilä, V., Puolakkainen, P. A., Kylänpää, L., & Kuuliala, K. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2019.1700548 · Cited by 4
Chiu, C.-C., Wang, Y., Huang, W.-C., Chen, Y., Hung, S., Huang, Y.-T., Chuang, H.-L., & Chang, Y. (2017) · Toxins · doi:10.3390/toxins9070224 · Cited by 4
Rawat, K., Pal, A., Banerjee, S., Pal, A., Chatterjee, P. N., & Batabyal, S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.30.555538 · Cited by 4
Insights from Interleukin-6 trans-signaling and implications for the control of cytokine activity
Rose‐John, S. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120109 · Cited by 3
Self-citationBiological Modifiers of Inflammatory Diseases
Chatham, W. (2019) · Clinical Immunology · doi:10.1016/b978-0-7020-6896-6.00089-2 · Cited by 2
How can antibiotics worsen acute kidney injury but improve survival in experimental sepsis?*
Souza, A. C. P., & Yuen, P. S. T. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318236e162 · Cited by 3
Ding, W., Moattari, C. R., Stohl, L. L., Wagner, J. A., Zhou, X. K., & Granstein, R. D. (2025) · Immunology · doi:10.1111/imm.13892 · Cited by 2
Posttraumatic Immune Response and Its Modulation
Hildebrand, F., Flohé, S., Leenen, L. P. H., van Griensven, M., & Frink, M. (2012) · Mediators of Inflammation · doi:10.1155/2012/731563 · Cited by 2
Liu, X., Liu, Y., Chen, Y., Zhao, C., Zhou, P., & Hu, Z. (2026) · Shock · doi:10.1097/shk.0000000000002843 · Cited by 1
Refining therapeutic targeting of interleukin-6 by signalling mode selectivity
Rose‐John, S., Waetzig, G. H., & Schreiber, S. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-026-01536-x · Cited by 1
Self-citationRéponse de l’endothélium microvasculaire à l’inflammation aiguë
Joffre, J., Pirracchio, R., & Legrand, M. M. (2020) · Anesthésie & Réanimation · doi:10.1016/j.anrea.2020.07.005 · Cited by 2
Zinina, E. P., Tsarenko, S. V., Logunov, D. Y., Ильдарович, Т. А., Магомедов, М. А., Babayants, A. V., & Avramov, A. A. (2022) · Annals of critical care · doi:10.21320/1818-474x-2021-4-48-58 · Cited by 1
Kurdowska, A., & Krupa, A. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318215c0ba · Cited by 1
New insights into the role and signalling processes of gp130
Rose‐John, S. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3414 · Cited by 1
Self-citationInterleukin-6 antagonism in a rat model of acute myocardial infarction
George, M. J. (2019) · UCL Discovery (University College London) · Cited by 1
Targeting COVID-19 Based on PathogenesisPreprint
Chong, Z. Z., & Zhang, H. (2024) · doi:10.22541/au.170665667.71444709/v1
Rose‐John, S. (2014) · Cytokine · doi:10.1016/j.cyto.2014.07.241
Self-citationPL2-2. Molecular Switch between Pro- and Anti-Inflammatory Cytokine Activities
Rose‐John, S. (2011) · Cytokine · doi:10.1016/j.cyto.2011.07.296
Self-citationDie Rolle von Pentraxin 3 und Interleukin-6-Transsignaling im Rahmen des Polytraumas
Becker, C. A. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-11037
The Biology of Interleukin-6, a Major Target in Anti-Inflammatory Therapies
Chalaris, A., Rose‐John, S., & Garbers, C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.10004-9
Self-citationEconomides, A. N., & Stahl, N. (2013) · Wiley eBooks · doi:10.1002/9781118354599.ch9
Innate immune memory in fibroblasts
Crowley, T. E. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham)
Sinardja, J., Darwin, E., Decroli, E., & Tjong, D. H. (2019) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/1675
Río, A. G.-D. (2019) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/36270
The immunological and vascular effects of IL-6 signalling in transplant arteriosclerosis
Montgomery, A. (2019) · Summit (Simon Fraser University)
Xu, Q., Wang, T., & Lü, W. (2021) · Open Life Sciences · doi:10.1515/biol-2021-0088
Rose‐John, S. (2021) · Springer eBooks · doi:10.1007/978-3-030-57401-7_10025
Self-citationBoslem, E., Riebe, S., Smeuninx, B., Egan, C. L., Tegegne, S., McLennan, E. D., Nobis, M., Mu, A., Nowell, C. J., Horadagoda, N. U., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4001943
Self-citationCriddle, D. N., & Javed, M. A. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717980878.793473612
Rose‐John, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-21573-6_10025-1
Self-citationImmunosuppressive Therapy in Giant Cell Arteritis: Do Steroids Still Reign Supreme?
Zhao, M. Y., Dhanani, U. M., Charoenkijkajorn, C., Pakravan, M., Mortensen, P. W., & Lee, A. G. (2022) · touchREVIEWS in Ophthalmology · doi:10.17925/usor.2022.16.2.85
The Biology of Interleukin-6: A Major Target in Anti-Inflammatory Therapies
Rose‐John, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-128-24465-4.00103-4
Self-citationLiu, Y., Gao, S., Li, Z., Yin, L., Ge, S., Zhao, Y., Wang, H., Wan, B., & Shao, Q. (2025) · Journal of Inflammation · doi:10.1186/s12950-025-00447-9
El-Husseini, Z. W., Khalenkow, D., Lan, A., van der Molen, T., Brightling, C., Papi, A., Rabe, K. F., Siddiqui, S., Singh, D., Kraft, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651094
Self-citationEl-Husseini, Z. W., Khalenkow, D., Lan, A., van der Molen, T., Brightling, C., Papi, A., Rabe, K. F., Siddiqui, S., Singh, D., Kraft, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26651091
Self-citationКаминный, А. И., Shuvalova, Y. A., Kaminnaya, V. I., & Палеев, Ф. Н. (2025) · Russian Cardiology Bulletin · doi:10.17116/cardiobulletin2025200415
Qin, J., Song, L., Zhou, H., Hao, Q., & Zhu, Z. (2026) · Journal of Interferon & Cytokine Research · doi:10.1177/10799907261432941
Serum meprin α levels for the detection of systemic inflammatory response syndrome
Beckinger, S., Mengel, M., Lindner, M., Köhling, V., Peters, F., Götting, I., Stoske, J., Rusch, J., Radke, D. I., Schädler, D., et al. (2026) · Molecular Medicine · doi:10.1186/s10020-026-01570-w
Rieneck, E., Haak, J. R., Asgarov, K., Pallandre, J., Wundrack, N., Ettich, J., Miri, N., Floss, D. M., Scheller, J., Garbers, C., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-11014-0
Self-citationThe Senescent Cell Induced Bystander Effect
Wordsworth, J. (2014)
Metadata
- Authors
- Barkhausen, T., Tschernig, T., Rosenstiel, P., van Griensven, M., Vonberg, R.-P., Dorsch, M., Mueller-Heine, A., Chalaris, A., Scheller, J., Rose-John, S., Seegert, D., Krettek, C., & Waetzig, G. H.
- Affiliations
- Christian-Albrechts-Universität zu Kiel (DE)
- ORCID
- Venue
- Critical Care Medicine
- Published
- 2011-06
- Volume
- 39
- Issue
- 6
- Pages
- 1407-1413
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W2319958192
- Cited by
- 169
- References
- 50
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 11 · 2023: 13 · 2022: 10 · 2021: 20 · 2020: 10 · 2019: 15 · 2018: 9 · 2017: 15 · 2016: 9 · 2015: 8 · 2014: 7 · 2013: 9 · 2012: 8
- FWCI
- 8.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- interleukin-6, IL-6 trans-signaling, soluble gp130, sgp130Fc, soluble IL-6 receptor, anti-IL-6 antibody, polymicrobial sepsis, cecal ligation and puncture, sepsis mortality, cytokine inhibition, IL-6 receptor signaling, dose-response relationship
- MeSH terms
- Interleukin-6 Inhibitors, Animals, Disease Models, Animal, Dose-Response Relationship, Drug, Male, Mice, Inbred C57BL, Recombinant Fusion Proteins, Signal Transduction, Interleukin-6, Sepsis, Mice, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
